nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.136	0.216	CbGbCtD
Palonosetron—CYP3A4—Triamcinolone—ankylosing spondylitis	0.103	0.164	CbGbCtD
Palonosetron—CYP3A4—Betamethasone—ankylosing spondylitis	0.0886	0.141	CbGbCtD
Palonosetron—CYP3A4—Prednisolone—ankylosing spondylitis	0.0875	0.139	CbGbCtD
Palonosetron—CYP3A4—Prednisone—ankylosing spondylitis	0.0826	0.131	CbGbCtD
Palonosetron—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0811	0.129	CbGbCtD
Palonosetron—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0516	0.0817	CbGbCtD
Palonosetron—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00133	0.00359	CcSEcCtD
Palonosetron—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00132	0.00359	CcSEcCtD
Palonosetron—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00132	0.00358	CcSEcCtD
Palonosetron—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.0013	0.00352	CcSEcCtD
Palonosetron—Erythema—Triamcinolone—ankylosing spondylitis	0.00129	0.0035	CcSEcCtD
Palonosetron—Erythema—Methylprednisolone—ankylosing spondylitis	0.00129	0.00349	CcSEcCtD
Palonosetron—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00129	0.00349	CcSEcCtD
Palonosetron—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00127	0.00343	CcSEcCtD
Palonosetron—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00126	0.00341	CcSEcCtD
Palonosetron—Eye disorder—Betamethasone—ankylosing spondylitis	0.00126	0.00341	CcSEcCtD
Palonosetron—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00122	0.00331	CcSEcCtD
Palonosetron—Angiopathy—Betamethasone—ankylosing spondylitis	0.00122	0.00331	CcSEcCtD
Palonosetron—Convulsion—Prednisolone—ankylosing spondylitis	0.00122	0.0033	CcSEcCtD
Palonosetron—Hypertension—Prednisolone—ankylosing spondylitis	0.00121	0.00329	CcSEcCtD
Palonosetron—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.0012	0.00326	CcSEcCtD
Palonosetron—Arrhythmia—Betamethasone—ankylosing spondylitis	0.0012	0.00326	CcSEcCtD
Palonosetron—Bradycardia—Prednisone—ankylosing spondylitis	0.00119	0.00324	CcSEcCtD
Palonosetron—Alopecia—Dexamethasone—ankylosing spondylitis	0.00119	0.00323	CcSEcCtD
Palonosetron—Alopecia—Betamethasone—ankylosing spondylitis	0.00119	0.00323	CcSEcCtD
Palonosetron—Discomfort—Prednisolone—ankylosing spondylitis	0.00118	0.0032	CcSEcCtD
Palonosetron—Erythema—Dexamethasone—ankylosing spondylitis	0.00117	0.00318	CcSEcCtD
Palonosetron—Erythema—Betamethasone—ankylosing spondylitis	0.00117	0.00318	CcSEcCtD
Palonosetron—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00115	0.00312	CcSEcCtD
Palonosetron—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00115	0.00311	CcSEcCtD
Palonosetron—Shock—Prednisolone—ankylosing spondylitis	0.00113	0.00306	CcSEcCtD
Palonosetron—Convulsion—Triamcinolone—ankylosing spondylitis	0.00112	0.00303	CcSEcCtD
Palonosetron—Tachycardia—Prednisolone—ankylosing spondylitis	0.00112	0.00303	CcSEcCtD
Palonosetron—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00112	0.00303	CcSEcCtD
Palonosetron—Hypertension—Triamcinolone—ankylosing spondylitis	0.00112	0.00302	CcSEcCtD
Palonosetron—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00111	0.00302	CcSEcCtD
Palonosetron—Myalgia—Triamcinolone—ankylosing spondylitis	0.0011	0.00298	CcSEcCtD
Palonosetron—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.0011	0.00298	CcSEcCtD
Palonosetron—Myalgia—Methylprednisolone—ankylosing spondylitis	0.0011	0.00298	CcSEcCtD
Palonosetron—Eye disorder—Prednisone—ankylosing spondylitis	0.0011	0.00297	CcSEcCtD
Palonosetron—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00109	0.00296	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00109	0.00295	CcSEcCtD
Palonosetron—Discomfort—Triamcinolone—ankylosing spondylitis	0.00109	0.00295	CcSEcCtD
Palonosetron—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00109	0.00294	CcSEcCtD
Palonosetron—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00108	0.00292	CcSEcCtD
Palonosetron—Angiopathy—Prednisone—ankylosing spondylitis	0.00106	0.00288	CcSEcCtD
Palonosetron—Immune system disorder—Prednisone—ankylosing spondylitis	0.00106	0.00287	CcSEcCtD
Palonosetron—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00106	0.00286	CcSEcCtD
Palonosetron—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00105	0.00285	CcSEcCtD
Palonosetron—Arrhythmia—Prednisone—ankylosing spondylitis	0.00105	0.00284	CcSEcCtD
Palonosetron—Infection—Triamcinolone—ankylosing spondylitis	0.00105	0.00284	CcSEcCtD
Palonosetron—Infection—Methylprednisolone—ankylosing spondylitis	0.00105	0.00283	CcSEcCtD
Palonosetron—Shock—Triamcinolone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Palonosetron—Insomnia—Prednisolone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Palonosetron—Alopecia—Prednisone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Palonosetron—Shock—Methylprednisolone—ankylosing spondylitis	0.00104	0.00281	CcSEcCtD
Palonosetron—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00103	0.0028	CcSEcCtD
Palonosetron—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00103	0.0028	CcSEcCtD
Palonosetron—Epistaxis—Methotrexate—ankylosing spondylitis	0.00103	0.00279	CcSEcCtD
Palonosetron—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00103	0.00279	CcSEcCtD
Palonosetron—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00103	0.00279	CcSEcCtD
Palonosetron—Mental disorder—Prednisone—ankylosing spondylitis	0.00103	0.00279	CcSEcCtD
Palonosetron—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00103	0.00278	CcSEcCtD
Palonosetron—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00102	0.00277	CcSEcCtD
Palonosetron—Erythema—Prednisone—ankylosing spondylitis	0.00102	0.00277	CcSEcCtD
Palonosetron—Malnutrition—Prednisone—ankylosing spondylitis	0.00102	0.00277	CcSEcCtD
Palonosetron—Convulsion—Dexamethasone—ankylosing spondylitis	0.00102	0.00275	CcSEcCtD
Palonosetron—Convulsion—Betamethasone—ankylosing spondylitis	0.00102	0.00275	CcSEcCtD
Palonosetron—Hypertension—Dexamethasone—ankylosing spondylitis	0.00101	0.00274	CcSEcCtD
Palonosetron—Hypertension—Betamethasone—ankylosing spondylitis	0.00101	0.00274	CcSEcCtD
Palonosetron—Myalgia—Dexamethasone—ankylosing spondylitis	0.000999	0.00271	CcSEcCtD
Palonosetron—Myalgia—Betamethasone—ankylosing spondylitis	0.000999	0.00271	CcSEcCtD
Palonosetron—Anxiety—Dexamethasone—ankylosing spondylitis	0.000995	0.0027	CcSEcCtD
Palonosetron—Anxiety—Betamethasone—ankylosing spondylitis	0.000995	0.0027	CcSEcCtD
Palonosetron—Discomfort—Dexamethasone—ankylosing spondylitis	0.000987	0.00267	CcSEcCtD
Palonosetron—Discomfort—Betamethasone—ankylosing spondylitis	0.000987	0.00267	CcSEcCtD
Palonosetron—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000984	0.00267	CcSEcCtD
Palonosetron—Pain—Prednisolone—ankylosing spondylitis	0.000981	0.00266	CcSEcCtD
Palonosetron—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000969	0.00262	CcSEcCtD
Palonosetron—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000962	0.0026	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000961	0.0026	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000959	0.0026	CcSEcCtD
Palonosetron—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000958	0.00259	CcSEcCtD
Palonosetron—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000958	0.00259	CcSEcCtD
Palonosetron—Insomnia—Triamcinolone—ankylosing spondylitis	0.000954	0.00259	CcSEcCtD
Palonosetron—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000952	0.00258	CcSEcCtD
Palonosetron—Infection—Betamethasone—ankylosing spondylitis	0.000951	0.00258	CcSEcCtD
Palonosetron—Infection—Dexamethasone—ankylosing spondylitis	0.000951	0.00258	CcSEcCtD
Palonosetron—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000948	0.00257	CcSEcCtD
Palonosetron—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000945	0.00256	CcSEcCtD
Palonosetron—Anaemia—Prednisone—ankylosing spondylitis	0.000944	0.00256	CcSEcCtD
Palonosetron—Shock—Betamethasone—ankylosing spondylitis	0.000942	0.00255	CcSEcCtD
Palonosetron—Shock—Dexamethasone—ankylosing spondylitis	0.000942	0.00255	CcSEcCtD
Palonosetron—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000941	0.00255	CcSEcCtD
Palonosetron—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000939	0.00254	CcSEcCtD
Palonosetron—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000939	0.00254	CcSEcCtD
Palonosetron—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000935	0.00253	CcSEcCtD
Palonosetron—Tachycardia—Betamethasone—ankylosing spondylitis	0.000935	0.00253	CcSEcCtD
Palonosetron—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000929	0.00252	CcSEcCtD
Palonosetron—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000927	0.00251	CcSEcCtD
Palonosetron—Eye disorder—Methotrexate—ankylosing spondylitis	0.000917	0.00248	CcSEcCtD
Palonosetron—Tinnitus—Methotrexate—ankylosing spondylitis	0.000915	0.00248	CcSEcCtD
Palonosetron—Anorexia—Dexamethasone—ankylosing spondylitis	0.000913	0.00247	CcSEcCtD
Palonosetron—Anorexia—Betamethasone—ankylosing spondylitis	0.000913	0.00247	CcSEcCtD
Palonosetron—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00091	0.00247	CcSEcCtD
Palonosetron—Fatigue—Triamcinolone—ankylosing spondylitis	0.00091	0.00246	CcSEcCtD
Palonosetron—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000908	0.00246	CcSEcCtD
Palonosetron—Pain—Triamcinolone—ankylosing spondylitis	0.000902	0.00244	CcSEcCtD
Palonosetron—Hypotension—Betamethasone—ankylosing spondylitis	0.000895	0.00242	CcSEcCtD
Palonosetron—Hypotension—Dexamethasone—ankylosing spondylitis	0.000895	0.00242	CcSEcCtD
Palonosetron—Angiopathy—Methotrexate—ankylosing spondylitis	0.00089	0.00241	CcSEcCtD
Palonosetron—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000886	0.0024	CcSEcCtD
Palonosetron—Convulsion—Prednisone—ankylosing spondylitis	0.000885	0.0024	CcSEcCtD
Palonosetron—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000884	0.00239	CcSEcCtD
Palonosetron—Hypertension—Prednisone—ankylosing spondylitis	0.000882	0.00239	CcSEcCtD
Palonosetron—Chills—Methotrexate—ankylosing spondylitis	0.00088	0.00238	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000872	0.00236	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000872	0.00236	CcSEcCtD
Palonosetron—Arthralgia—Prednisone—ankylosing spondylitis	0.00087	0.00236	CcSEcCtD
Palonosetron—Myalgia—Prednisone—ankylosing spondylitis	0.00087	0.00236	CcSEcCtD
Palonosetron—Anxiety—Prednisone—ankylosing spondylitis	0.000867	0.00235	CcSEcCtD
Palonosetron—Alopecia—Methotrexate—ankylosing spondylitis	0.000867	0.00235	CcSEcCtD
Palonosetron—Insomnia—Dexamethasone—ankylosing spondylitis	0.000866	0.00235	CcSEcCtD
Palonosetron—Insomnia—Betamethasone—ankylosing spondylitis	0.000866	0.00235	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000864	0.00234	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000861	0.00233	CcSEcCtD
Palonosetron—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00086	0.00233	CcSEcCtD
Palonosetron—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00086	0.00233	CcSEcCtD
Palonosetron—Discomfort—Prednisone—ankylosing spondylitis	0.000859	0.00233	CcSEcCtD
Palonosetron—Mental disorder—Methotrexate—ankylosing spondylitis	0.000859	0.00233	CcSEcCtD
Palonosetron—Erythema—Methotrexate—ankylosing spondylitis	0.000854	0.00231	CcSEcCtD
Palonosetron—Malnutrition—Methotrexate—ankylosing spondylitis	0.000854	0.00231	CcSEcCtD
Palonosetron—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000845	0.00229	CcSEcCtD
Palonosetron—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000843	0.00228	CcSEcCtD
Palonosetron—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000843	0.00228	CcSEcCtD
Palonosetron—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000836	0.00226	CcSEcCtD
Palonosetron—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000834	0.00226	CcSEcCtD
Palonosetron—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000834	0.00226	CcSEcCtD
Palonosetron—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000832	0.00225	CcSEcCtD
Palonosetron—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000832	0.00225	CcSEcCtD
Palonosetron—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000832	0.00225	CcSEcCtD
Palonosetron—Infection—Prednisone—ankylosing spondylitis	0.000828	0.00224	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000827	0.00224	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000827	0.00224	CcSEcCtD
Palonosetron—Fatigue—Dexamethasone—ankylosing spondylitis	0.000826	0.00224	CcSEcCtD
Palonosetron—Fatigue—Betamethasone—ankylosing spondylitis	0.000826	0.00224	CcSEcCtD
Palonosetron—Shock—Prednisone—ankylosing spondylitis	0.00082	0.00222	CcSEcCtD
Palonosetron—Pain—Dexamethasone—ankylosing spondylitis	0.000819	0.00222	CcSEcCtD
Palonosetron—Pain—Betamethasone—ankylosing spondylitis	0.000819	0.00222	CcSEcCtD
Palonosetron—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000818	0.00222	CcSEcCtD
Palonosetron—Tachycardia—Prednisone—ankylosing spondylitis	0.000814	0.0022	CcSEcCtD
Palonosetron—Skin disorder—Prednisone—ankylosing spondylitis	0.00081	0.00219	CcSEcCtD
Palonosetron—Anorexia—Prednisone—ankylosing spondylitis	0.000795	0.00215	CcSEcCtD
Palonosetron—Anaemia—Methotrexate—ankylosing spondylitis	0.000789	0.00214	CcSEcCtD
Palonosetron—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000783	0.00212	CcSEcCtD
Palonosetron—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000783	0.00212	CcSEcCtD
Palonosetron—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000777	0.00211	CcSEcCtD
Palonosetron—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000776	0.0021	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00076	0.00206	CcSEcCtD
Palonosetron—Dizziness—Prednisolone—ankylosing spondylitis	0.000759	0.00206	CcSEcCtD
Palonosetron—Asthenia—Triamcinolone—ankylosing spondylitis	0.000757	0.00205	CcSEcCtD
Palonosetron—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000757	0.00205	CcSEcCtD
Palonosetron—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000757	0.00205	CcSEcCtD
Palonosetron—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000757	0.00205	CcSEcCtD
Palonosetron—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000757	0.00205	CcSEcCtD
Palonosetron—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000755	0.00205	CcSEcCtD
Palonosetron—Insomnia—Prednisone—ankylosing spondylitis	0.000754	0.00204	CcSEcCtD
Palonosetron—Paraesthesia—Prednisone—ankylosing spondylitis	0.000749	0.00203	CcSEcCtD
Palonosetron—Pruritus—Triamcinolone—ankylosing spondylitis	0.000747	0.00202	CcSEcCtD
Palonosetron—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000745	0.00202	CcSEcCtD
Palonosetron—Convulsion—Methotrexate—ankylosing spondylitis	0.00074	0.002	CcSEcCtD
Palonosetron—Dyspepsia—Prednisone—ankylosing spondylitis	0.000734	0.00199	CcSEcCtD
Palonosetron—Myalgia—Methotrexate—ankylosing spondylitis	0.000727	0.00197	CcSEcCtD
Palonosetron—Arthralgia—Methotrexate—ankylosing spondylitis	0.000727	0.00197	CcSEcCtD
Palonosetron—Decreased appetite—Prednisone—ankylosing spondylitis	0.000725	0.00196	CcSEcCtD
Palonosetron—Rash—Prednisolone—ankylosing spondylitis	0.000724	0.00196	CcSEcCtD
Palonosetron—Dermatitis—Prednisolone—ankylosing spondylitis	0.000723	0.00196	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000722	0.00196	CcSEcCtD
Palonosetron—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00072	0.00195	CcSEcCtD
Palonosetron—Fatigue—Prednisone—ankylosing spondylitis	0.000719	0.00195	CcSEcCtD
Palonosetron—Headache—Prednisolone—ankylosing spondylitis	0.000719	0.00195	CcSEcCtD
Palonosetron—Discomfort—Methotrexate—ankylosing spondylitis	0.000718	0.00195	CcSEcCtD
Palonosetron—Constipation—Prednisone—ankylosing spondylitis	0.000713	0.00193	CcSEcCtD
Palonosetron—Dizziness—Triamcinolone—ankylosing spondylitis	0.000698	0.00189	CcSEcCtD
Palonosetron—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000697	0.00189	CcSEcCtD
Palonosetron—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000696	0.00189	CcSEcCtD
Palonosetron—Infection—Methotrexate—ankylosing spondylitis	0.000692	0.00188	CcSEcCtD
Palonosetron—Asthenia—Dexamethasone—ankylosing spondylitis	0.000687	0.00186	CcSEcCtD
Palonosetron—Asthenia—Betamethasone—ankylosing spondylitis	0.000687	0.00186	CcSEcCtD
Palonosetron—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000683	0.00185	CcSEcCtD
Palonosetron—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000682	0.00185	CcSEcCtD
Palonosetron—Nausea—Prednisolone—ankylosing spondylitis	0.000682	0.00185	CcSEcCtD
Palonosetron—Pruritus—Dexamethasone—ankylosing spondylitis	0.000677	0.00183	CcSEcCtD
Palonosetron—Pruritus—Betamethasone—ankylosing spondylitis	0.000677	0.00183	CcSEcCtD
Palonosetron—Skin disorder—Methotrexate—ankylosing spondylitis	0.000677	0.00183	CcSEcCtD
Palonosetron—Vomiting—Triamcinolone—ankylosing spondylitis	0.000671	0.00182	CcSEcCtD
Palonosetron—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000669	0.00181	CcSEcCtD
Palonosetron—Rash—Triamcinolone—ankylosing spondylitis	0.000665	0.0018	CcSEcCtD
Palonosetron—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000665	0.0018	CcSEcCtD
Palonosetron—Anorexia—Methotrexate—ankylosing spondylitis	0.000664	0.0018	CcSEcCtD
Palonosetron—Rash—Methylprednisolone—ankylosing spondylitis	0.000664	0.0018	CcSEcCtD
Palonosetron—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000663	0.0018	CcSEcCtD
Palonosetron—Headache—Triamcinolone—ankylosing spondylitis	0.000661	0.00179	CcSEcCtD
Palonosetron—Headache—Methylprednisolone—ankylosing spondylitis	0.00066	0.00179	CcSEcCtD
Palonosetron—Body temperature increased—Prednisone—ankylosing spondylitis	0.000659	0.00179	CcSEcCtD
Palonosetron—Abdominal pain—Prednisone—ankylosing spondylitis	0.000659	0.00179	CcSEcCtD
Palonosetron—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000655	0.00177	CcSEcCtD
Palonosetron—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000655	0.00177	CcSEcCtD
Palonosetron—Hypotension—Methotrexate—ankylosing spondylitis	0.000651	0.00176	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000635	0.00172	CcSEcCtD
Palonosetron—Dizziness—Dexamethasone—ankylosing spondylitis	0.000633	0.00172	CcSEcCtD
Palonosetron—Dizziness—Betamethasone—ankylosing spondylitis	0.000633	0.00172	CcSEcCtD
Palonosetron—Insomnia—Methotrexate—ankylosing spondylitis	0.00063	0.00171	CcSEcCtD
Palonosetron—Nausea—Triamcinolone—ankylosing spondylitis	0.000627	0.0017	CcSEcCtD
Palonosetron—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000626	0.00169	CcSEcCtD
Palonosetron—Nausea—Methylprednisolone—ankylosing spondylitis	0.000625	0.00169	CcSEcCtD
Palonosetron—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000621	0.00168	CcSEcCtD
Palonosetron—Somnolence—Methotrexate—ankylosing spondylitis	0.00062	0.00168	CcSEcCtD
Palonosetron—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000614	0.00166	CcSEcCtD
Palonosetron—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000613	0.00166	CcSEcCtD
Palonosetron—Vomiting—Dexamethasone—ankylosing spondylitis	0.000609	0.00165	CcSEcCtD
Palonosetron—Vomiting—Betamethasone—ankylosing spondylitis	0.000609	0.00165	CcSEcCtD
Palonosetron—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000606	0.00164	CcSEcCtD
Palonosetron—Rash—Dexamethasone—ankylosing spondylitis	0.000604	0.00164	CcSEcCtD
Palonosetron—Rash—Betamethasone—ankylosing spondylitis	0.000604	0.00164	CcSEcCtD
Palonosetron—Dermatitis—Betamethasone—ankylosing spondylitis	0.000603	0.00163	CcSEcCtD
Palonosetron—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000603	0.00163	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000602	0.00163	CcSEcCtD
Palonosetron—Fatigue—Methotrexate—ankylosing spondylitis	0.000601	0.00163	CcSEcCtD
Palonosetron—Headache—Betamethasone—ankylosing spondylitis	0.0006	0.00162	CcSEcCtD
Palonosetron—Headache—Dexamethasone—ankylosing spondylitis	0.0006	0.00162	CcSEcCtD
Palonosetron—Asthenia—Prednisone—ankylosing spondylitis	0.000598	0.00162	CcSEcCtD
Palonosetron—Pain—Methotrexate—ankylosing spondylitis	0.000596	0.00161	CcSEcCtD
Palonosetron—Pruritus—Prednisone—ankylosing spondylitis	0.00059	0.0016	CcSEcCtD
Palonosetron—Diarrhoea—Prednisone—ankylosing spondylitis	0.000571	0.00155	CcSEcCtD
Palonosetron—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00057	0.00154	CcSEcCtD
Palonosetron—Nausea—Dexamethasone—ankylosing spondylitis	0.000569	0.00154	CcSEcCtD
Palonosetron—Nausea—Betamethasone—ankylosing spondylitis	0.000569	0.00154	CcSEcCtD
Palonosetron—Dizziness—Prednisone—ankylosing spondylitis	0.000551	0.00149	CcSEcCtD
Palonosetron—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000551	0.00149	CcSEcCtD
Palonosetron—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000551	0.00149	CcSEcCtD
Palonosetron—Vomiting—Prednisone—ankylosing spondylitis	0.00053	0.00144	CcSEcCtD
Palonosetron—Rash—Prednisone—ankylosing spondylitis	0.000526	0.00142	CcSEcCtD
Palonosetron—Dermatitis—Prednisone—ankylosing spondylitis	0.000525	0.00142	CcSEcCtD
Palonosetron—Headache—Prednisone—ankylosing spondylitis	0.000522	0.00141	CcSEcCtD
Palonosetron—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000513	0.00139	CcSEcCtD
Palonosetron—Asthenia—Methotrexate—ankylosing spondylitis	0.0005	0.00135	CcSEcCtD
Palonosetron—Nausea—Prednisone—ankylosing spondylitis	0.000495	0.00134	CcSEcCtD
Palonosetron—Pruritus—Methotrexate—ankylosing spondylitis	0.000493	0.00134	CcSEcCtD
Palonosetron—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000477	0.00129	CcSEcCtD
Palonosetron—Dizziness—Methotrexate—ankylosing spondylitis	0.000461	0.00125	CcSEcCtD
Palonosetron—Vomiting—Methotrexate—ankylosing spondylitis	0.000443	0.0012	CcSEcCtD
Palonosetron—Rash—Methotrexate—ankylosing spondylitis	0.000439	0.00119	CcSEcCtD
Palonosetron—Dermatitis—Methotrexate—ankylosing spondylitis	0.000439	0.00119	CcSEcCtD
Palonosetron—Headache—Methotrexate—ankylosing spondylitis	0.000437	0.00118	CcSEcCtD
Palonosetron—Nausea—Methotrexate—ankylosing spondylitis	0.000414	0.00112	CcSEcCtD
